The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Review Article
Free Access

Detection of disseminated prostate cells by reverse transcription‐polymerase chain reaction (RT‐PCR): Technical and clinical aspects

Eva Corey

Corresponding Author

E-mail address:ecorey@u.washington.edu

Genitourinary Research Cancer Laboratory of the Urology Department, the School of Medicine of the University of Washington, Seattle, WA, USA

Urology Department, Mail Stop 356510, the School of Medicine of the University of Washington, Seattle, WA 98195, USA. Fax: (206) 543–1146
Search for more papers by this author
Michael J. Corey

Genitourinary Research Cancer Laboratory of the Urology Department, the School of Medicine of the University of Washington, Seattle, WA, USA

Search for more papers by this author
First page image

Number of times cited: 24

  • , Isolated, disseminated and circulating tumour cells in prostate cancer, Nature Reviews Urology, 9, 8, (448), (2012).
  • , Bone marrow micrometastases in different solid tumors: Pathogenesis and importance, Surgical Oncology, 17, 3, (153), (2008).
  • , Development of a high‐throughput membrane‐array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers, International Journal of Cancer, 119, 2, (373-379), (2006).
  • , Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer – A Pilot Study, Tumor Biology, 27, 2, (104), (2006).
  • , Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective, European Journal of Surgical Oncology (EJSO), 10.1053/ejso.2002.1394, 29, 4, (289-302), (2003).
  • , DNA Alterations in Body Fluids as Molecular Tumor Markers for Urological Malignancies, European Urology, 10.1016/S0302-2838(02)00126-4, 41, 6, (668-676), (2002).
  • , DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates, Annals of the New York Academy of Sciences, 945, 1, (51-58), (2006).
  • , Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation, International Journal of Cancer, 92, 4, (577-582), (2001).
  • , A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model, Journal of Orthopaedic Science, 6, 3, (269), (2001).
  • , Molecular characterization of minimal residual cancer cells in patients with solid tumors, Biomolecular Engineering, 10.1016/S1389-0344(00)00073-3, 17, 3, (95-111), (2001).
  • , Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for the Measurement of Prostate-Specific Antigen mRNA in the Peripheral Blood of Patients with Prostate Carcinoma Using the TaqManTM Detection System, Clinical Chemistry and Laboratory Medicine, 39, 5, (2001).
  • , Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status, Urology, 58, 3, (386), (2001).
  • , Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample, Biological Procedures Online, 3, 1, (19), (2001).
  • , Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using “Light-Cycler”-based quantitative real-time polymerase chain reaction, Urology, 58, 5, (815), (2001).
  • , Detection of extraprostatic prostate cells utilizing reverse transcription‐polymerase chain reaction, Seminars in Surgical Oncology, 18, 1, (17-28), (1999).
  • , RT‐PCR‐Based Detection of Occult Disseminated Tumor Cells in Peripheral Blood and Bone Marrow of Patients with Solid Tumors: An Overview, Annals of the New York Academy of Sciences, 906, 1, (110-123), (2006).
  • , Detecting circulating prostate cells in patients with clinically localized prostate cancer: clinical implications for molecular staging, BJU International, 86, 9, (1023-1027), (2001).
  • , DETECTION OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH PROSTATE ADENOCARCINOMA IS AN INDEPENDENT RISK FACTOR FOR TUMOR RECURRENCE, The Journal of Urology, 163, 6, (2022), (2000).
  • , DETECTION OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH PROSTATE ADENOCARCINOMA IS AN INDEPENDENT RISK FACTOR FOR TUMOR RECURRENCE, The Journal of Urology, (2022), (2000).
  • , Detection and Clinical Importance of Micrometastatic Disease, JNCI Journal of the National Cancer Institute, 91, 13, (1113), (1999).
  • , RE, The Journal of Urology, (925), (1999).
  • , RE: THE VALUE OF A REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION ASSAY IN PREOPERATIVE STAGING AND FOLLOWUP OF PATIENTS WITH PROSTATE CANCER, The Journal of Urology, 161, 3, (925), (1999).
  • , DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION, The Journal of Urology, (1076), (1999).
  • , EDITORIAL COMMENT, The Journal of Urology, 161, 4, (1076), (1999).